AIM: AIM ImmunoTech Inc. Earnings growth forecast for next year
A critical dependence on a single drug creates binary risks for AIM ImmunoTech (AIM), which directly impacts consensus expectations for n+1 profit dynamics, where the indicator value is 36.50. Revenues are based on the development of anti-cancer and anti-viral agents, with drug production provided by US CMO partners. The curve's dynamics allow for the timely detection of a cycle phase shift and the risk of capital correction.
Analytical breakdowns for AIM ImmunoTech
- price and consensus price forecast:
- market capitalization information:
- book capitalization indicators:
- issuer credit burden and liquidity indicators:
- earnings and valuation multiples information:
AIM - Net Income|Future Profit AIM ImmunoTech|AIM - P/E Multiple|Future Price to Earnings AIM ImmunoTech|AIM - Growth-Adjusted P/E Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AIM ImmunoTech|AIM - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months AIM ImmunoTech|AIM - Earnings per share for the last four quarters|Quarterly EPS earnings growth aimimmuno.com|AIM - Earnings per share growth rate in current year|Earnings growth forecast for next year AIM ImmunoTech
Fundamental company valuation:AIM ImmunoTech, AIM
An analysis of next year's EPS forecast trends for AIM ImmunoTech reflects consolidated expert expectations regarding the growth rates of net income per share. This metric assesses future business efficiency, where the potential to scale production through the modernization of cleanrooms directly determines the likelihood of achieving the yield targets set by analysts and the overall investment attractiveness of the asset.
Competitor analysis
Net earnings per share growth forecast for next year Argenx|Projected earnings per share growth rate for next year BNTX (BioNTech Pharma)|Earnings growth forecast for next year ABVX|ADMA - Expected net earnings per share growth next year|Earnings growth forecast for next year PTGX (Protagonist)|Earnings growth forecast for next year Immunovant Inc IMVT|Kiniksa Pharmaceuticals Ltd - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Grifols Biemat GRFS|Adaptive Biotechnologies (ADPT) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year celldex.com|Expected earnings per share growth for next year AUPH|BCRX: Expected earnings per share trend next year|Earnings growth forecast for next year VERA|Consensus forecast of earnings per share growth for next year Dianthus Corp|Net earnings per share growth forecast for next year Pharvaris N.V. PHVS|ABCL - Expected earnings per share growth for next year|TRML - Net earnings per share growth forecast for next year|Precigen Inc (PGEN) - Expected earnings per share growth for next year|PHAR (Pharming) - Expected earnings per share growth for next year|Nektar Corp (NKTR) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Upstream Bio Inc|Projected earnings per share growth rate for next year ZBIO (zenasbio.com)|Net earnings per share growth forecast for next year Immunome (IMNM)|GOSS - Expected net earnings per share growth next year|KalVista Pharmaceuticals Inc - Expected earnings per share growth for next year|Projected earnings per share increase next year SEPN (Septerna Pharma)|Pieris Pharmaceuticals - Earnings growth forecast for next year|Expected net earnings per share growth next year savarapharma.com|RIGL: Earnings growth forecast for next year|Expected earnings per share growth for next year AnaptysBio Inc|ATXS (Astria Pharma) - Earnings growth forecast for next year|ENGN: Expected earnings per share trend next year|Earnings growth forecast for next year RAPT|Earnings growth forecast for next year aerovatetx.com (JBIO)|Earnings growth forecast for next year ACRS (Aclaris Therapeutics, Inc.)|Consensus forecast of earnings per share growth for next year Kyverna Therapeutics Inc. (KYTX)|TLSA - Net earnings per share growth forecast for next year|Cabaletta Bio Inc (CABA) - Expected earnings per share growth for next year|Ventyx Biosciences (VTYX) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year THTX (theratech.com)|AVTX (Avalo Therapeutics) - Earnings growth forecast for next year|ELDN: Expected earnings per share trend next year|Earnings growth forecast for next year AGEN|Earnings growth forecast for next year Climb Bio, Inc (CLYM)|Net earnings per share growth forecast for next year Zura Bio Limited ZURA|Expected earnings per share trend next year ATYR|ADAG - Net earnings per share growth forecast for next year|ImageneBio Inc (IMA) - Expected earnings per share growth for next year|STTK: Earnings growth forecast for next year|Equillium (EQ) - Earnings growth forecast for next year|Expected earnings per share growth for next year CNTB|IMUX: Expected earnings per share trend next year|Earnings growth forecast for next year ATRA|Consensus forecast of earnings per share growth for next year inflarx.de|Net earnings per share growth forecast for next year X4 Pharma XFOR|ACET - Expected earnings per share growth for next year|CELU - Net earnings per share growth forecast for next year|inmunebio.com (INMB) - Expected earnings per share growth for next year|BRNS (Barinthus Biotherapeutics plc) - Expected earnings per share growth for next year|Kezar Life Sciences Inc. (KZR) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year SAB Biotherapeutics, Inc|Projected earnings per share growth rate for next year AKTX (Akari Therapeutics, Plc)|Earnings growth forecast for next year ENLV|QTTB - Expected net earnings per share growth next year|Earnings growth forecast for next year GOVX (GeoVax)|Earnings growth forecast for next year Edesa Biotech Inc EDSA|iBio Corp - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Carisma Therapeutics CARM|XTL Biopharmaceuticals (XTLB) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Bolt Biotherapeutics, Inc.|Expected earnings per share growth for next year HCWB|APVO: Expected earnings per share trend next year|Earnings growth forecast for next year ADTX|Consensus forecast of earnings per share growth for next year GRI Bio Corporation|Net earnings per share growth forecast for next year XORTX Therapeutics Inc. XRTX|HIND - Expected earnings per share growth for next year|REVB - Net earnings per share growth forecast for next year|Indaptus Therapeutics Inc (INDP) - Expected earnings per share growth for next year|SCNI (Scinai) - Expected earnings per share growth for next year|CalciMedica (CALI) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Affimed NV|Projected earnings per share growth rate for next year ALLK (Allakos Therapeutics)|Net earnings per share growth forecast for next year HOOKIPA Pharma Inc. (HOOK)|IGMS - Expected net earnings per share growth next year|iTeos - Expected earnings per share growth for next year|Projected earnings per share increase next year OCEA (Ocean Biomedical Corp)|TC Biopharm - Earnings growth forecast for next year|Expected net earnings per share growth next year thirdharmonicbio.com
